Myocardial, Pericardial Diseases and Cardiomyopathy

Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and Management Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE Recurrent Pericarditis for Professionals From Referral to Recovery: Maximizing Enrollment and Participation in Cardiac Rehabilitation miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction Plasma Protein Profile Associated With a Family History of Early-Onset Coronary Heart Disease Cardiac Troponin Is Infrequently Tested at Emergency Department Visits With Suspected Acute Ischemic Stroke Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD Letter by Kornelius Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users” Interaction Between Chronotype and the Timing of Antihypertensive Medication on Cardiovascular Events and Death